Home
    Disclaimer
    FXE molecular structure

    FXE Stats & Data

    3f-o-pce fluorexetamine
    Psychoactive Class Dissociative
    Half-Life Unknown in humans; user reports suggest short–moderate elimination (roughly a few hours), but no formal PK data located.

    Effect Profile

    Curated + 7 Reports
    Dissociative 6.0

    Strong dissociative depth and motor impairment with mild mania, low insight

    Dissociative Depth×3
    10
    Mania / Compulsion×1
    4
    Insight / Novel Thought×2
    3
    Motor / Sensory Impairment×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki
    Half-Life
    Unknown in humans; user reports suggest short–moderate elimination (roughly a few hours), but no formal PK data located.
    Addiction Potential
    Moderate; dissociatives can foster compulsive redosing and psychological dependence, particularly with frequent use.

    Tolerance Decay

    Full tolerance 1d Half tolerance 7d Baseline ~14d

    Estimates are based on dissociative class patterns and user reports rather than controlled studies. Cross‑tolerance within arylcyclohexylamines is common; allowing 2–4+ weeks between sessions reduces tolerance significantly.

    Cross-Tolerances

    Ketamine
    70% ●○○
    MXE (Methoxetamine)
    70% ●○○
    O‑PCE
    70% ●○○
    2‑FDCK
    60% ●○○
    DXM
    50% ●○○

    Experience Report Analysis

    Erowid
    7 Reports
    2022–2024 Date Range
    7 With Age Data
    11 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 7 experience reports (7 Erowid)

    7 Reports
    11 Effects Detected
    7 Positive
    1 Adverse
    3 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 7

    Euphoria 85.7% 70%
    Empathy 85.7% 70%
    Color Enhancement 71.4% 70%
    Music Enhancement 71.4% 70%
    Stimulation 71.4% 70%
    Introspection 42.9% 70%
    Tactile Enhancement 42.9% 70%

    Adverse Effects 1

    Motor Impairment 42.9% 70%

    Real-World Dose Distribution

    62K Doses

    From 8 individual dose entries

    Insufflated (n=8)

    Median: 55.0mg 25th: 41.25mg 75th: 126.25mg 90th: 184.0mg
    mg/kg median: 0.836 mg/kg 75th: 1.996

    Form / Preparation

    Most common forms and preparations reported

    Harm Reduction

    drugs.wiki

    - Identity and purity vary in the unregulated market; drug checking is strongly recommended. Toronto’s Drug Checking Service and similar services often detect unexpected actives in samples; start with an allergy dose and avoid unknown vendors.

    - Combining dissociatives with CNS depressants (alcohol, benzos, opioids, GHB/GBL) greatly increases risks of blackout, airway compromise, and respiratory depression; place anyone unconscious in the recovery position and call emergency services.

    - Frequent/heavy arylcyclohexylamine use is linked to ulcerative cystitis and other urinary tract injury (data strongest for ketamine). Given structural similarity and user reports, apply the same precautions to FXE: minimize frequency, stay well‑hydrated during/after use, and stop if urinary pain/urgency/hematuria emerge.

    - Dissociatives can impair coordination and judgment; sit or lie down during peaks, avoid heights/water, and strictly avoid driving/operating machinery until fully baseline the next day. Ketamine references note sedation and slowed breathing at high doses—caution is extrapolated to FXE.

    - High or prolonged dissociative intoxication can precipitate rhabdomyolysis; seek urgent care if you develop severe muscle pain, dark (tea‑colored) urine, or decreased urination after a session.

    - Insufflation irritates nasal mucosa and encourages redosing. To reduce harm: use separate, clean straws; rotate nostrils; space sessions; and gently rinse with sterile saline 15–30 minutes post‑use. General community HR guidance supports nasal care.

    - Intramuscular use has appeared in community reports but carries additional risks (infection, dosing errors). If someone chooses IM, sterile technique, micron filtration, and accurate volumetric dosing are essential; this is not recommended for novices.

    - Tolerance to dissociatives builds rapidly; even weekly use can markedly blunt effects, encouraging escalation. Long breaks (2–4+ weeks) help reset tolerance.

    - FXE is often described as ketamine‑like with unique nuances; individuals vary widely in sensitivity. Dose conservatively, especially if on serotonergic meds (limited human interaction data for FXE; MXE showed SRI activity).

    - Because FXE is sold as a research chemical, mislabeling/adulteration occur. Visually atypical powders and unexpected effects warrant immediate cessation and testing; some user reports describe anomalous batches.

    ← Back to FXE